- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- September 2022
- 104 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2022
- 93 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2022
- 172 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- May 2023
- 272 Pages
- Book
- August 2019
- 264 Pages
- Book
- January 2018
- 144 Pages
- Book
- December 2016
- 528 Pages
- Book
- October 2013
- 144 Pages

Tachycardia is a type of cardiac arrhythmia characterized by an abnormally rapid heart rate. It is a common condition that affects people of all ages and can be caused by a variety of factors, including physical activity, stress, and certain medications. Treatment for tachycardia typically involves lifestyle modifications, medications, and/or medical procedures.
The tachycardia market is a subset of the larger cardiology market, which is estimated to be worth billions of dollars. The tachycardia market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the growing demand for advanced treatments.
Some of the major players in the tachycardia market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, St. Jude Medical, and Biotronik. These companies offer a range of products and services, including diagnostic and therapeutic devices, medications, and medical procedures. Show Less Read more